A gentle touch: could massage ease Chemo's constipation?
NCT ID NCT07007468
First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time
Summary
This trial tests whether a simple, non-invasive abdominal massage can prevent constipation in breast cancer patients undergoing chemotherapy. Constipation is a common and distressing side effect of chemo, affecting up to 90% of patients. The study will compare patients who receive the massage to those who don't, measuring constipation severity and quality of life. If it works, this could offer a safe, drug-free way to improve comfort during cancer treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Abdominal massage
- What this could lead to
- If effective, abdominal massage could become a simple, drug-free way to prevent constipation in chemotherapy patients, improving comfort and quality of life.
- What could go wrong
- This is a small, early-stage trial, and results may not apply to all patients. The massage may not be effective for everyone, and individual responses can vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
88 people
The number who actually took part.
- Started
-
Jun 2025
- Finished
-
Jul 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18 years of age or older, * Receiving chemotherapy for breast cancer that causes constipation * Patients who received at least one cycle of chemotherapy and experienced chemotherapy-associated constipation within five days of treatment (stool type 1 or 2 according to the Bristol Stool Scale) * Volunteers who are willing to participate in the research, can communicate, and can read and write, * Without psychiatric illness and abdominal obstruction, * No mass in the abdominal region was detected, * No intestinal bleeding, * No history of radiation therapy to the abdominal region, * No surgical procedures in the abdominal region, * Patients without intra-abdominal infection, inflammatory bowel disease and irritable bowel syndrome will be included Exclusion Criteria: * Patients with stool type 3, 4, 5, 6 and 7 points according to the Bristol Stool Scale
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istanbul University-Cerrahpasa Florence Nightingale Faculty of Nursing
Istanbul, Marmara, 34381, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Retrospective analysis of pyrotinib in the treatment of HER2-Positive advanced breast cancer previously treated with trastuzumab and pertuzumab
- Mind and body: does resilience leave a molecular mark in breast cancer?
- Which pain block works better for breast surgery?
- Can a Triple-Drug combo erase HER2-Positive breast tumors before surgery?
- Bacteria inside tumors may hold the key to breast cancer treatment
- Can a newer drug ease the bone pain of chemotherapy support?